Stanford Medicine researchers have developed a blood test capable of detecting cancers, the ways cancer resists treatments ...

Valued at a market cap of $9.6 billion, Cambridge, Massachusetts-based Moderna, Inc. (MRNA) is a biotechnology company that ...

Older adults with cancer respond just as well as younger patients to immune checkpoint inhibitors despite age-related immune system differences, according to a study by researchers from the Johns ...

Pausing treatment during vaccination did not improve immunity in patients with chronic lymphocytic leukemia and should not be ...